Immunotherapy treatments harnessing the immune system herald a new era of personalized
medicine, offering considerable benefits for cancer patients. Over the past years, tumor …

Imaging mass cytometry (IMC) enables the in situ analysis of in-depth-phenotyped cells in
their native microenvironment within the preserved architecture of a single tissue section. To …

The long-term survival of patients with advanced urothelial carcinoma (UCa) is limited
because of innate resistance to treatment. We identified elevated expression of the histone …

Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …

B7x (also called B7-H4) is a co-inhibitory molecule of B7 family that is highly expressed in
non-inflamed or cold cancers, and its aberrant expression is contributed to cancer …

Cancer immunotherapy, including the inhibition of immune checkpoints, improves the tumor
immune microenvironment and is an effective tool for cancer therapy. More effective and …

The aim of present study was to investigate the beneficial effect of chromium (III) picolinate
(CrPic) and chromium (III) picolinate nanoparticles (NCrPic) addition on growth …

Simple Summary Bladder cancer (BC) development is highly related to immune cell
infiltration. In this study, we aimed to construct a new classification of bladder cancer …

High-grade serous ovarian carcinoma (HGSC) is the most lethal gynecologic malignancy.
While immune checkpoint inhibitors against PD-L1 and CTLA-4 have shown significant …

Bladder cancer (BC) is the 10th most common cancer worldwide, with about 0.5 million
reported new cases and about 0.2 million deaths per year. In this scoping review, we …